Genetics of Liver Disease in Adults

Overview

Journal Hepatol Commun

Specialty Gastroenterology

Date 2024 Mar 29

PMID 38551385

Authors

Chigoziri Konkwo

Shanin Chowdhury

Silvia Vilarinho

Affiliations

Soon will be listed here.

Abstract

Chronic liver disease stands as a significant global health problem with an estimated 2 million annual deaths across the globe. Combining the use of next-generation sequencing technologies with evolving knowledge in the interpretation of genetic variation across the human genome is propelling our understanding, diagnosis, and management of both rare and common liver diseases. Here, we review the contribution of risk and protective alleles to common forms of liver disease, the rising number of monogenic diseases affecting the liver, and the role of somatic genetic variants in the onset and progression of oncological and non-oncological liver diseases. The incorporation of genomic information in the diagnosis and management of patients with liver disease is driving the beginning of a new era of genomics-informed clinical hepatology practice, facilitating personalized medicine, and improving patient care.

Citing Articles

Liver diseases: epidemiology, causes, trends and predictions.

Gan C, Yuan Y, Shen H, Gao J, Kong X, Che Z Signal Transduct Target Ther. 2025; 10(1):33.

PMID: 39904973 PMC: 11794951. DOI: 10.1038/s41392-024-02072-z.

Exome-wide association analysis identifies novel risk loci for alcohol-associated hepatitis.

Yuan Q, Hodgkinson C, Liu X, Barton B, Diazgranados N, Schwandt M Hepatology. 2024; .

PMID: 39058584 PMC: 11902603. DOI: 10.1097/HEP.0000000000001027.

References

Fleming R, Migas M, Holden C, Waheed A, Britton R, Tomatsu S . Transferrin receptor 2: continued expression in mouse liver in the face of iron overload and in hereditary hemochromatosis. Proc Natl Acad Sci U S A. 2000; 97(5):2214-9. PMC: 15780. DOI: 10.1073/pnas.040548097. View

Bluteau O, Jeannot E, Bioulac-Sage P, Marques J, Blanc J, Bui H . Bi-allelic inactivation of TCF1 in hepatic adenomas. Nat Genet. 2002; 32(2):312-5. DOI: 10.1038/ng1001. View

Hayeems R, Bhawra J, Tsiplova K, Meyn M, Monfared N, Bowdin S . Care and cost consequences of pediatric whole genome sequencing compared to chromosome microarray. Eur J Hum Genet. 2017; 25(12):1303-1312. PMC: 5865210. DOI: 10.1038/s41431-017-0020-3. View

Devane J, Ott E, Olinger E, Epting D, Decker E, Friedrich A . Progressive liver, kidney, and heart degeneration in children and adults affected by TULP3 mutations. Am J Hum Genet. 2022; 109(5):928-943. PMC: 9118107. DOI: 10.1016/j.ajhg.2022.03.015. View

Wu A, McMahon P, Lu C . Ending the Diagnostic Odyssey-Is Whole-Genome Sequencing the Answer?. JAMA Pediatr. 2020; 174(9):821-822. PMC: 7928067. DOI: 10.1001/jamapediatrics.2020.1522. View

Nault J, Couchy G, Balabaud C, Morcrette G, Caruso S, Blanc J . Molecular Classification of Hepatocellular Adenoma Associates With Risk Factors, Bleeding, and Malignant Transformation. Gastroenterology. 2016; 152(4):880-894.e6. DOI: 10.1053/j.gastro.2016.11.042. View

Stockley R, Turner A . α-1-Antitrypsin deficiency: clinical variability, assessment, and treatment. Trends Mol Med. 2014; 20(2):105-15. DOI: 10.1016/j.molmed.2013.11.006. View

James K, Clark M, Camp B, Kint C, Schols P, Batalov S . Partially automated whole-genome sequencing reanalysis of previously undiagnosed pediatric patients can efficiently yield new diagnoses. NPJ Genom Med. 2020; 5:33. PMC: 7419288. DOI: 10.1038/s41525-020-00140-1. View

Webb G, Hirschfield G . Using GWAS to identify genetic predisposition in hepatic autoimmunity. J Autoimmun. 2015; 66:25-39. DOI: 10.1016/j.jaut.2015.08.016. View

10.

Choi M, Scholl U, Ji W, Liu T, Tikhonova I, Zumbo P . Genetic diagnosis by whole exome capture and massively parallel DNA sequencing. Proc Natl Acad Sci U S A. 2009; 106(45):19096-101. PMC: 2768590. DOI: 10.1073/pnas.0910672106. View

11.

Hirschfield G, Karlsen T, Lindor K, Adams D . Primary sclerosing cholangitis. Lancet. 2013; 382(9904):1587-99. DOI: 10.1016/S0140-6736(13)60096-3. View

12.

Roper J, Tammela T, Malli Cetinbas N, Akkad A, Roghanian A, Rickelt S . In vivo genome editing and organoid transplantation models of colorectal cancer and metastasis. Nat Biotechnol. 2017; 35(6):569-576. PMC: 5462879. DOI: 10.1038/nbt.3836. View

13.

Panzer M, Viveiros A, Schaefer B, Baumgartner N, Seppi K, Djamshidian A . Synonymous mutation in adenosine triphosphatase copper-transporting beta causes enhanced exon skipping in Wilson disease. Hepatol Commun. 2022; 6(7):1611-1619. PMC: 9234614. DOI: 10.1002/hep4.1922. View

14.

Jager M, Blokzijl F, Sasselli V, Boymans S, Janssen R, Besselink N . Measuring mutation accumulation in single human adult stem cells by whole-genome sequencing of organoid cultures. Nat Protoc. 2017; 13(1):59-78. DOI: 10.1038/nprot.2017.111. View

15.

Guan Y, Enejder A, Wang M, Fang Z, Cui L, Chen S . A human multi-lineage hepatic organoid model for liver fibrosis. Nat Commun. 2021; 12(1):6138. PMC: 8536785. DOI: 10.1038/s41467-021-26410-9. View

16.

Hakim A, Moll M, Brancale J, Liu J, Lasky-Su J, Silverman E . Genetic Variation in the Mitochondrial Glycerol-3-Phosphate Acyltransferase Is Associated With Liver Injury. Hepatology. 2021; 74(6):3394-3408. PMC: 8639615. DOI: 10.1002/hep.32038. View

17.

Avena A, Puggelli S, Morris M, Cerny A, Reparaz Andrade A, Pareti E . ABCB4 variants in adult patients with cholestatic disease are frequent and underdiagnosed. Dig Liver Dis. 2021; 53(3):329-344. DOI: 10.1016/j.dld.2020.12.003. View

18.

Eslam M, George J . Genetic contributions to NAFLD: leveraging shared genetics to uncover systems biology. Nat Rev Gastroenterol Hepatol. 2019; 17(1):40-52. DOI: 10.1038/s41575-019-0212-0. View

19.

Mann J, Hoare M . A minority of somatically mutated genes in pre-existing fatty liver disease have prognostic importance in the development of NAFLD. Liver Int. 2022; 42(8):1823-1835. PMC: 9544140. DOI: 10.1111/liv.15283. View

20.

Roetto A, Papanikolaou G, Politou M, Alberti F, Girelli D, Christakis J . Mutant antimicrobial peptide hepcidin is associated with severe juvenile hemochromatosis. Nat Genet. 2002; 33(1):21-2. DOI: 10.1038/ng1053. View